- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03093766
Balance Study on ICU-acquired Hypernatremia and Sodium Handling (BIAS) (BIAS)
July 17, 2018 updated by: Medical Centre Leeuwarden
Balance Study on ICU-acquired Hypernatremia and Sodium Handling
The goal of this study is to find differences between patients who do and do not develop ICU-acquired hypernatremia (IAH).
Therefore extended sodium and fluid balances will be performed.
Also a couple of other factors that possibly contribute to the development of IAH and/or could give clues about the mechanisms in the development of IAH will be investigated.
Study Overview
Status
Completed
Conditions
Detailed Description
ICU-acquired hypernatremia (IAH) is common in critically ill patients, but it's aetiology is still not fully understood.
Sodium overload and inadequate fluid administration are generally considered important factors, but a previous retrospective study did not reveal differences in sodium or fluid balances between patients who did and did not develop IAH.
Because this was retrospective these balances will be prospectively studied in this study to be more sure about the importances of these balances in the development of IAH.
Previous studies indicated that (a lot) more factors contribute to the development of IAH.
In this study these factors will be investigated, hoping to find differences between patients who do and do not develop IAH.
Study Type
Observational
Enrollment (Actual)
155
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leeuwarden, Netherlands
- Medisch Centrum Leeuwarden
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All unplanned ICU-admissions
Description
Inclusion Criteria:
- Predicted duration of ICU-admission >48 hours
Exclusion Criteria:
- Renal replacement therapy
- Reason for admission necessitates actively elevation of serum sodium concentration
- Electrolyte disturbance as reason for admission
- ICU re-admission within 30 days
- Referral from another ICU
- Serum sodium concentration on admission 143mmol/l or above
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sodium balance
Time Frame: During ICU-admission
|
Differences in sodium balances between patients who do and do not develop IAH
|
During ICU-admission
|
Fluid balance
Time Frame: During ICU-admission
|
Differences in fluid balances between patients who do and do not develop IAH
|
During ICU-admission
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kidney function
Time Frame: During ICU-admission
|
Differences in parameters concerning kidney function (creatinine, urea) between patients who do and do not develop IAH
|
During ICU-admission
|
Inflammation
Time Frame: During ICU-admission
|
Differences in inflammation (CRP, infections) between patients who do and do not develop IAH
|
During ICU-admission
|
Nutritional state
Time Frame: During ICU-admission
|
Differences in nutritional state (albumin, BIVA-measurement) between patients who do and do not develop IAH
|
During ICU-admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Christiaan Boerma, Medical Center Leeuwarden
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care. 2013 Jan 21;17(1):R12. doi: 10.1186/cc11937.
- van IJzendoorn MC, Buter H, Kingma WP, Navis GJ, Boerma EC. The Development of Intensive Care Unit Acquired Hypernatremia Is Not Explained by Sodium Overload or Water Deficit: A Retrospective Cohort Study on Water Balance and Sodium Handling. Crit Care Res Pract. 2016;2016:9571583. doi: 10.1155/2016/9571583. Epub 2016 Sep 14.
- Bihari S, Ou J, Holt AW, Bersten AD. Inadvertent sodium loading in critically ill patients. Crit Care Resusc. 2012 Mar;14(1):33-7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 7, 2017
Primary Completion (ACTUAL)
April 16, 2018
Study Completion (ACTUAL)
June 1, 2018
Study Registration Dates
First Submitted
March 22, 2017
First Submitted That Met QC Criteria
March 27, 2017
First Posted (ACTUAL)
March 28, 2017
Study Record Updates
Last Update Posted (ACTUAL)
July 18, 2018
Last Update Submitted That Met QC Criteria
July 17, 2018
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZRTPO 996
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Collected data will be available through an online portal / storage website as soon as the manuscript was published.
From that moment data can be obtained after a request via the online portal / storage website.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ICU-acquired Hypernatremia
-
Saglik Bilimleri UniversitesiMedical Park Hospital IstanbulCompletedICU Patients | ICU Acquired WeaknessTurkey
-
Lulu GuActive, not recruitingTrauma Injury | ICU Acquired Weakness | ICUChina
-
Fresno Community Hospital and Medical CenterWestern University of Health SciencesRecruitingICU Acquired WeaknessUnited States
-
Zagazig UniversityNot yet recruiting
-
Asan Medical CenterCompleted
-
Chinese PLA General HospitalUnknownRehabilitation | ICU Acquired Weakness
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Groupe Hospitalier du HavreRecruitingICU Acquired WeaknessFrance
-
Centre Hospitalier Universitaire VaudoisUnknown